apollo
Online Doctor Consultation & Medicines

COVID-19 Vaccines

Part II: Debunking COVID-19 Vaccine Myths with Facts

3 min read

By Apollo 24/7, Published on - 09 February 2021, Updated on - 18 October 2022

COVID-19 Vaccines: Myths and FactsConclusion

  • Share this article

  • 1

  • 5 likes

Debunking COVID-19 Vaccine Myths with Facts
As of January 29, 2020, more than 3 million healthcare workers in India have received the first dose of one of the two approved COVID-19 vaccines. If everything goes well, the country will soon begin immunizing the other priority beneficiaries covered under the first phase of the COVID-19 vaccination programme. Given the significance of the vaccination in ending the pandemic, it is important to bust some of the myths that have come to be associated with the vaccines.

COVID-19 Vaccines: Myths and Facts

Myth #1: People who have recovered from COVID-19 don’t need vaccines

Fact: Given the risk of severe illness associated with COVID-19 and the possibility of reinfection, people who have recovered from COVID-19 before should still get vaccinated. Currently, not much is known about the nature and extent of natural immunity acquired from COVID-19 infection. According to some studies, natural infection-acquired immunity is not robust and may not last very long. On the other hand, the immunity generated by the COVID-19 vaccines is likely to be powerful and relatively long-lasting. Therefore, scientists say that people who have recovered from COVID-19 should still be vaccinated. 

Myth #2: People with underlying medical conditions shouldn’t get a COVID-19 vaccine

Fact: People with underlying medical conditions such as diabetes, hypertension, heart disease, etc. are at a higher risk of severe and life-threatening COVID-19 complications. Therefore, it is important for such people to get vaccinated once COVID-19 vaccines are available to them. However, people with immune disorders and those with a history of allergic reactions should share their medical history with the officials at the vaccination site before getting vaccinated.

Myth #3: Healthy people with good immune function don’t need a COVID-19 vaccine

Fact: It is true that older adults, people with poor immunity, and those with underlying health conditions are at a greater risk of life-threatening COVID-19 complications. However, healthy individuals with a relatively good immune function can still contract COVID-19 and experience severe symptoms. Such people can also spread the virus to others. According to health experts, vaccines will protect everyone from severe and life-threatening COVID-19 complications. Getting a vaccine will also help stop virus transmission and protect vulnerable people in families and communities. Therefore, it is recommended that even healthy adults should get vaccines once it is available to them.

Myth #4: People who have received the COVID-19 vaccines will test positive for the virus

Fact: A COVID-19 diagnostic test involves taking samples from the respiratory system of an individual to check for the presence of the SARS-CoV-2 virus that causes COVID-19. However, none of the approved COVID-19 vaccines contains live strains of the virus. Therefore, the vaccines are unlikely to affect the results of the diagnostic tests. Nevertheless, it is still possible to get infected with the virus before the vaccine has generated full immunity which can take up to 2 weeks after the second dose.

Myth #5: People who have received COVID-19 vaccines can stop wearing masks

Fact: Vaccines can only prevent individuals from developing moderate to severe COVID-19; however, they cannot stop the SARS-CoV-2 virus from entering the body. It is still not known clearly whether vaccinated individuals can carry and transmit the virus or not, even if they don’t get ill themselves. Therefore, it is important for people who have received COVID-19 vaccines to continue to follow precautionary measures like wearing face masks, practicing hand hygiene, and maintaining physical distancing. Public health experts will likely revise the infection prevention guidelines once a sufficient number of people have been immunized.

Conclusion

Countries all over the world are fighting the misinformation campaign targeting COVID-19 vaccines. The fight is likely to continue throughout the pandemic. Till now, India has been fairly successful in dealing with this menace. But the problem will require continuous efforts. More and more facts would need to be disseminated as and when new misinformation starts circulating. We can trust vaccines to do their job. But we will have to do ours too.

Services

References+7

COVID-19 Vaccines

Comments+1

Leave Comment

Name

Email Id

Comment

Services

Recommended for you

Article Entity

COVID-19 Vaccines

COVID-19 Vaccines: How effective are they in the real world?

Recently, several scientific studies have been released highlighting the difference between the clinical efficacy of some of the top COVID-19 vaccines and their real-world effectiveness.

Article Entity

COVID-19 Vaccines

Dosage interval of Covishield vaccine revised to 4 to 8 weeks

The dosage interval of Covishield vaccine has been revised to 4 to 8 weeks after the 1st dose instead of the earlier practised interval of 4-6 weeks.

Article Entity

COVID-19 Vaccines

Frequently Asked Questions on COVID-19 vaccines

India has recently granted the ‘emergency use authorisation’ of two vaccines - Covishield and Covaxin to fight the Coronavirus.

Subscribe

Sign up for our free Health Library Daily Newsletter

Get doctor-approved health tips, news, and more.

Email

Visual Stories

story-img

COVID-19 Weekly Vaccine Round-Up [11th May 2021]

Tap to continue exploring

  • Share this article

  • 1

  • 5 likes

Recommended for you

Article Entity

COVID-19 Vaccines

COVID-19 Vaccines: How effective are they in the real world?

Recently, several scientific studies have been released highlighting the difference between the clinical efficacy of some of the top COVID-19 vaccines and their real-world effectiveness.

Article Entity

COVID-19 Vaccines

Dosage interval of Covishield vaccine revised to 4 to 8 weeks

The dosage interval of Covishield vaccine has been revised to 4 to 8 weeks after the 1st dose instead of the earlier practised interval of 4-6 weeks.

Article Entity

COVID-19 Vaccines

Frequently Asked Questions on COVID-19 vaccines

India has recently granted the ‘emergency use authorisation’ of two vaccines - Covishield and Covaxin to fight the Coronavirus.